Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Therapeutics

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0149-2918(00)90005-5PMID 10929918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of Non-Insulin-Dependent Diabetes Mellitus

  2012cited by this paper
• Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors

  2004cited by this paper
• Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus

  1999cited by this paper
• Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

  1999cited by this paper
• Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus

  1999cited by this paper
• The Effects of Metformin on Glycemic Control and Serum Lipids in Insulin-Treated NIDDM Patients With Suboptimal Metabolic Control

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.

  1997cited by this paper
• GHb Is a Better Predictor of Cardiovascular Disease Than Fasting or Postchallenge Plasma Glucose in Women Without Diabetes: The Rancho Bernardo Study

  1996cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• The insulin-sparing effect of metformin in insulin-treated diabetic patients.

  1995cited by this paper
• Metformin and metoprolol CR treatment in non‐obese men

  1994cited by this paper
• Metabolic and Hemodynamic Effects of Metformin and Glibenclamide in Normotensive NIDDM Patients

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groups

  1993cited by this paper
• Biguanides and NIDDM

  1992cited by this paper
• Hypertension in Obesity and NIDDM: Role of Insulin and Sympathetic Nervous System

  1991cited by this paper
• Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.

  1991cited by this paper
• Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

  1991cited by this paper
• Insulin and Cardiovascular Disease: Paris Prospective Study

  1991cited by this paper
• Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

  1991cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Insulin and atheroma. 20-yr perspective.

  1990cited by this paper
• Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus.

  1990cited by this paper
• Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial.

  1990cited by this paper
• Glucose Toxicity

  1990cited by this paper
• Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients

  1990cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Beta-cell deficiency, insulin resistance, or both?

  1988cited by this paper
• The Effect of Glibenclamide and Metformin on Serum Lipoproteins in Type 2 Diabetes

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM

  1988cited by this paper
• [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics].

  1987cited by this paper
• Adipose tissue distribution, plasma insulin, and cardiovascular disease.

  1987cited by this paper
• Current approaches to measurement of insulin secretion.

  1986cited by this paper
• Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin-dependent diabetes mellitus.

  1983cited by this paper
• The two-period cross-over clinical trial.

  1979cited by this paper

• Effectiveness of Metformin Monotherapy vs. Metformin-Insulin Combination on Glycemic Control for Type 2 Diabetes in Eastern Libya

  2025cites this paper
• Stability -Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Alogliptin and Metformin in Bulk and Pharmaceutical Formulations

  2025cites this paper
• Analysis of molecular interactions in glucose-aqueous-human mixtard insulin/metformin solutions by volumetric, acoustic properties

  2025cites this paper
• Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus

  2024cites this paper
• The cost of influence: How gifts to physicians shape prescriptions and drug costs.

  2022cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2019

  2020cites this paper
• Phytochemical screening and preliminary clinical trials of the aqueous extract mixture of Andrographis paniculata (Burm. f.) Wall. ex Nees and Syzygium polyanthum (Wight.) Walp leaves in metformin treated patients with type 2 diabetes.

  2019cites this paper
• Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review

  2018cites this paper
• Administration of metformin in clinical medicine; an updated mini-review on current findings

  2018cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cites this paper
• Japanese Clinical Practice Guideline for Diabetes 2016

  2018cites this paper
• A new perspective on metformin therapy in type 1 diabetes

  2017cites this paper
• AMPK in the control of hepatic glucagon signalling and protein synthesis

  2017cites this paper
• The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion

  2016cites this paper
• Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines

  2016cites this paper
• Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.

  2016cites this paper
• Efficacy and safety of linagliptin as add‐on therapy to basal insulin and metformin in people with Type 2 diabetes

  2016cites this paper
• Treatment Approach to Patients With Severe Insulin Resistance

  2016cites this paper
• Simultaneous determination of linagliptin and metformin by reverse phase-high performance liquid chromatography method: An application in quantitative analysis of pharmaceutical dosage forms

  2015cites this paper
• Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes Mellitus

  2015cites this paper
• WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.

  2015cites this paper
• Individualization of oral antidiabetic therapy in patients with type 2 diabetes

  2013cites this paper
• Pharmacologic management of type 2 diabetes.

  2013cites this paper
• Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses

  2012cites this paper
• Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control

  2012cites this paper
• Controle glicêmico e lipídico de pacientes com diabete tipo 2 em tratamento combinado de metformina e insulina

  2010cites this paper
• Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes

  2010cites this paper
• Insulin therapy in type 2 diabetes patients : balancing between evidence and experience

  2010cites this paper
• The Continuation of Oral Medications with the Initiation of Insulin Therapy in Type 2 Diabetes: A Review of the Evidence

  2010cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cites this paper
• Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ2 Update der Evidenzbasierten Leitlinie der Deutschen Diabetes-Gesellschaft Pharmacological Antihyperglycemic Therapy of Type2 Diabetes mellitus Update of the Evidence-Based Guidelines of the German Diabetes Association

  2009cites this paper
• Insulin therapy in type 2 diabetes: what is the evidence?

  2009cites this paper
• Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus*

  2009cites this paper
• Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2

  2009cites this paper
• A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus.

  2008cites this paper
• [Types of insulin therapy].

  2008cites this paper
• Metformin and body weight

  2008cites this paper
• Use of Insulin in Type 2 diabetes : when Maximal Oral Therapy Fails

  2008cites this paper
• Tipos de insulinoterapia

  2008cites this paper
• Initiating insulin in type 2 diabetes

  2008cites this paper
• Addressing insulin resistance in Type 1 diabetes

  2008cites this paper
• Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes

  2008cites this paper
• Brief report A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients

  2007cites this paper
• A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.

  2007influential citation
• Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?

  2007cites this paper
• Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI

  2006cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2006cites this paper
• OUTPATIENT MANAGEMENT OF TYPE 2 DIABETIC PATIENTS: A REVIEW OF EVIDENCE-BASED LITERATURE

  2006cites this paper
• Manitoba Diabetes Care Project: Examining Trends in Diabetes Therapy Prescribing Patterns in Manitoba

  2006cites this paper
• Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus

  2005cites this paper
• Effektivität des PROSIT-Interventionsprogramms in Bezug auf die Blutglukoseeinstellung bei Typ 2-diabetischen Patienten

  2005cites this paper
• Metformin monotherapy for type 2 diabetes mellitus.

  2005cites this paper
• Association d'insuline et d'un biguanide pour administration orale contre le diabète

  2005cites this paper
• Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus.

  2004cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis.

  2003cites this paper
• Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.

  2003cites this paper
• [Modern approaches to pharmacotherapy of diabetes mellitus type II].

  2002cites this paper
• Glycemic Management of Diabetes in the Perioperative Setting

  2002cites this paper
• Scientific Review and Clinical Applications

  2002cites this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2002cites this paper
• Insulin Treatment in Type 2 Diabetes

  2001cites this paper
• Patient Preference and Adherence

  year unknowncites this paper